| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | PF 03814735 |
|---|
| Description | Purity ~98% (HPLC). ATP-competitive inhibitor of Aurora kinases A and B (IC50 values are 0.8 and 5nm for recombinant Aurora B and Aurora A, respectively). Inhibits phosphorylation of Aurora B, histone H3 and Aurora A in cultured MDA-MB-231 cells (IC50 values are ~20, 50 and 150nm respectively). Shown to block cytokinesis; inhibits cellular proliferation in several human tumor cell lines, including HCT-116, HL-60, A549 and H125, and in human xenograft mouse models. Orally available. Sequence: C23H25F3N6O2 Solubility: DMSO (~100mM), Ethanol (~20mM) Molecular Weight: ~474.48 |
|---|
| Size | 10mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | PF 03814735 (Aurora Kinases A and B, N-[2-[(1S,4R)-6-[[4-(Cyclobutylamin o)-5-(trifluoromethyl)-2-pyrimidinyl]amino]-1,2,3, 4-tetrahydronaphthalen-1,4-imin-9-yl]-2-oxoethyl]- acetamide) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 145687 |
|---|
| Price | |
|---|
| Order / More Info | PF 03814735 from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|